Three intragenic suppressors of a GTPase-deficient allele of GNAS associated with McCune-Albright syndrome

Journal of Molecular Endocrinology

Volumn 52, Issue 3, 2014, Pages 321-331

  Turcic, Kyle ^a   Tobar Rubin, Raquel ^a   Janevska, Daniela ^a   Carroll, Julie ^a   Din, Eraj ^a   Alvarez, Rebecca ^a   Haick, Jennifer ^a   Pals Rylaarsdam, Robin ^a  

^a BENEDICTINE UNIVERSITY   (United States)

Author keywords

CAMP; G protein; McCune Albright syndrome; Suppressor mutation

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CHORIONIC GONADOTROPIN; CYCLIC AMP; CYSTEINE; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; GNAS PROTEIN; GUANOSINE TRIPHOSPHATASE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; PHENYLALANINE; PROTEIN; SERINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TYROSINE; UNCLASSIFIED DRUG; GNAS PROTEIN, HUMAN; GPA1 PROTEIN, S CEREVISIAE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; SACCHAROMYCES CEREVISIAE PROTEIN;

ALBRIGHT SYNDROME; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; YEAST; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; FACIAL BONE; GENE LIBRARY; GENE REPRESSION; GENETICS; HEK293 CELL LINE; MUTATION; SACCHAROMYCES CEREVISIAE; SKULL; TUMOR CELL LINE;

AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; CYCLIC AMP; FACIAL BONES; FIBROUS DYSPLASIA, POLYOSTOTIC; GENE LIBRARY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEK293 CELLS; HUMANS; MUTATION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SKULL; SUPPRESSION, GENETIC;

EID: 84901334283     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0297     Document Type: Article

References (35)

1. Albright F., Butler AM, Hampton AO & Smith P 1937 Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 4 cases. New England Journal of Medicine 216 727-746. (doi:10.1056/ NEJM193704292161701)
2. Apanovitch D. M, Iiri T, Karasawa T, Bourne HR & Dohlman HG 1998 Second site suppressor mutations of a GTPase-deficient G-protein a-subunit. Selective inhibition of Gbg-mediated signaling. Journal of Biological Chemistry 273 28597-28602. (doi:10.1074/jbc.273.44.28597)
3. Candeliere G. A, Roughley PJ & Glorieux FH 1997 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in Gas from patients with fibrous dysplasia of bone. Bone 21 201-206. (doi:10.1016/S8756-3282(97)00107-5)
4. Chan B. & Zacharin M 2006 Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. Journal of Pediatric Endocrinology & Metabolism 19 75-80. (doi:10.1515/JPEM.2006.19.1.75)
5. Chen P., Johnson P, Sommer T, Jentsch S & Hochstrasser M 1993 Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MATa2 repressor. Cell 74 357-369. (doi:10.1016/0092-8674(93)90426-Q)
6. Clementi E., Malgaretti N, Meldolesi J & Taramelli R 1990 A new constitutively activating mutation of the Gs protein a subunit gsp oncogene is found in human pituitary tumours. Oncogene 5 1059-1061.
7. Coleman D. E & Sprang SR 1998 Crystal structures of the G protein Gia1 complexed with GCP and Mg2C: a crystallographic titration experiment. Biochemistry 37 14376-14385. (doi:10.1021/bi9810306)
8. Collins M. T 2006 Spectrum and natural history of fibrous dysplasia of bone, Journal of Bone and Mineral Research 21 (Suppl 2) P99-P104. (doi:10. 1359/jbmr.06s219)
9. Dohlman H. G & Jones JC 2012 Signal activation and inactivation by the Ga helical domain: a long-neglected partner in G protein signaling. Science Signaling 5 re2. (doi:10.1126/scisignal.2003013)
10. Dumitrescu C. E & Collins MT 2008 McCune-Albright syndrome. Orphanet Journal of Rare Diseases 3 12. (doi:10.1186/1750-1172-3-12)
11. Echeverria V., Hinrichs MV, Torrejon M, Ropero S, Martinez J, Toro MJ & Olate J. 2000 Mutagenesis in the switch IV of the helical domain of the human Gsa reduces Its GDP/GTP exchange rate. Journal of Cellular Biochemistry 76 368-375. (doi:10.1002/(SICI)1097-4644(20000301) 76:3!368::AID-JCB4O3.0.CO;2-B)
12. Eugster E. A, Rubin SD, Reiter EO, Plourde P, Jou HC & Pescovitz OH 2003 Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. Journal of Pediatrics 143 60-66. (doi:10.1016/S0022-3476(03)00128-8)
13. Farfel Z., Iiri T, Shapira H, Roitman A, Mouallem M & Bourne HR 1996 Pseudohypoparathyroidism, a novel mutation in the b/g-contact region of Gs-a impairs receptor stimulation. Journal of Biological Chemistry 271 19653-19655. (doi:10.1074/jbc.271.33.19653)
14. Feuillan P., Calis K, Hill S, Shawker T, Robey PG & Collins MT 2007 Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. Journal of Clinical Endocrinology and Metabolism 92 2100-2106. (doi:10.1210/jc.2006-2350)
15. Iiri T., Farfel Z & Bourne HR 1997 Conditional activation defect of a human Gs-a mutant. PNAS 94 5656-5661. (doi:10.1073/pnas.94.11.5656)
16. Ishikawa Y., Tajima T, Nakae J, Nagashima T, Satoh K, Okuhara K & Fujieda K Two mutations of the Gs-a gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia. Journal of Human Genetics 46 426-430. (doi:10.1007/s100380170062)
17. Landis C., Masters SB, Spada A, Pace AM, Bourne HR & Vallar L 1989 GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340 692-696. (doi:10.1038/ 340692a0)
18. Lania A. G, Mantonvani G & Spada A 2006 Mechanisms of disease: mutations of G proteins and G-protein coupled receptors in endocrine diseases. Nature Clinical Practice. Endocrinology & Metabolism 2 681-691. (doi:10.1038/ncpendmet0324)
19. Liens D., Delmas PD & Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343 953-954. (doi:10.1016/S0140-6736(94)90069-8)
20. Lumbroso S., Paris F & Sultan C 2004 Activating Gs-a mutations: analysis of 113 patients with signs of McCune-Albright syndrome-a European collaborative study. Journal of Clinical Endocrinology and Metabolism 89 2107-2113. (doi:10.1210/jc.2003-031225)
21. Lyons J., Landis CA, Harsh G, Vallar L, Grunwald K, Feichtinger H, Duh Q-Y, Clark O. H, Kawasaki E, Bourne HR et al. 1990 Two G protein oncogenes in human endocrine tumors. Science 249 655-659. (doi:10.1126/ science.2116665)
22. McCune D. J 1936 Osteitis fibrosa cystic: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. American Journal of Diseases of Children 36 743-744.
23. Medici R., Bianchi E, Di Segni G & Tocchini-Valentini GP 1997 Efficient signal transduction by a chimeric yeast-mammalian G protein a subunit Gpa1-Gsa covalently fused to the yeast receptor Ste2. EMBO Journal 16 7241-7249. (doi:10.1093/emboj/16.24.7241)
24. Mixon M. B, Lee E, Coleman DE, Berghuis AM, Gilman AG & Sprang SR 1995 Tertiary and quaternary structural changes in Gia1 induced by GTP hydrolysis. Science 270 954-960. (doi:10.1126/science.270.5238.954)
25. Mumberg D., Müller R & Funk M 1995 Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156 119-122. (doi:10.1016/0378-1119(95)00037-7)
26. Ooms L. S, KosterMJ, Mitchell JR & Pals-Rylaarsdam R 2006 Identification of a second-site suppressor mutation of the GTPase defect associated with McCune-Albright syndrome: a mode using the yeast heterotrimeric G protein, GPA1. Archives of Physiology and Biochemistry 112 116-173. (doi:10.1080/13813450600935271)
27. Plotkin H., Rauch F, Zeitlin L, Munns C, Travers R & Glorieux FH 2003 Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. Journal of Clinical Endocrinology and Metabolism 88 4569-4575. (doi:10.1210/jc.2003-030050)
28. Rasmussen S. G, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae P. S, Pardon E, Calinski D et al. 2011 Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477 549-555. (doi:10.1038/nature10361)
29. Riminucci M., Fisher LW, Majolagbe A, Corsi A, Lala R, de Sanctis C, Robey PG & Bianco P 1999 A novel GNAS1 mutation, R201G, in McCune-Albright syndrome. Journal of Bone and Mineral Research 14 1987-1989. (doi:10.1359/jbmr.1999.14.11.1987)
30. Schwindinger W. F, Francomano CA & Levine MA 1992 Identification of a mutation in the gene encoding the a subunit of the stimulatory G-protein of adenylyl cyclase in McCune-Albright syndrome. PNAS 89 5152-5156. (doi:10.1073/pnas.89.11.5152)
31. Stanton R. P, Ippolito E, Springfield D, Lindaman L, Wientroub S & Leet A The surgical management of fibrous dysplasia of bone. Orphanet Journal of Rare Diseases 7 (Suppl 1) S1. (doi:10.1186/1750-1172-7-S1-S1)
32. Sunahara R. K, Tesmer JJ, Gilman AG & Sprang SR 1997 Crystal structure of the adenylyl cyclase activator Gsa. Science 278 1943-1947. (doi:10.1126/science.278.5345.1943)
33. Tesmer J. J, Sunahara RK, Gilman AG & Sprang SR 1997 Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsa-GTPgS. Science 278 1907-1916. (doi:10.1126/science.278. 5345.1907)
34. Tobar-Rubin R., Sultan D, Janevska D, Turcic K, Carroll J & Pals-RylaarsdamR Intragenic suppression of a constitutively active allele of Gsa associated with McCune-Albright syndrome. Journal of Molecular Endocrinology 50 193-201. (doi:10.1530/JME-12-0087)
35. Weinstein L. S, Shenker A, Gejman PV, MerinoMJ, Friedman E & Spiegel AM Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New England Journal of Medicine 325 1688-1695. (doi:10.1056/NEJM199112123252403)